6505--Famciclovir Tablets

Amendment / Modification

This amendment extends the deadline for the receipt of offers for Solicitation 36E79726R0017.

• The hour and date specified for the receipt of offers is extended.

• The due date and time for receipt of offers is extended to April 6, 2026, at 2:30 PM Central Time (CT).

• Offerors must complete, sign, and submit this amendment with all other offer documents by the new deadline.

Solicitation / RFP / RFQ

This solicitation seeks proposals for the supply of Famciclovir tablets (125mg, 250mg, and 500mg) in bottles of 30 tablets. The contract will establish national contract prices for these pharmaceutical products, which will be distributed through the VA and DoD Pharmaceutical Prime Vendor (PPV) Programs. The objective is to ensure product availability and consistent pricing for nationwide usage.

• Famciclovir tablets in specified strengths and package sizes.

• Offerors must provide a unique 11-digit National Drug Code (NDC) for each offered drug.

• Products must meet FDA requirements and be manufactured in FDA cGMP acceptable facilities.

• Packaging must comply with specified requirements, including safety caps and compatibility with automated dispensing units.

• Bar code labeling at the unit-of-use package level is required.

• Compliance with Drug Supply Chain Security Act (DSCSA) requirements is mandatory.

• Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.

• Period of Performance: Includes an Implementation Period, a one-year Base Ordering Period, and four one-year option periods.

• Estimated quantities are provided for VA, DoD, BOP, and IHS.

• Proposals must be submitted via email to Richard.Mahario@va.gov and Nicholas.McGregor@va.gov, including a scanned copy of the signed SF-1449.

• Offers must include pricing for the base year and all four option years for all line items.

• Evaluation will be based on the lowest price technically acceptable (LPTA) offer.

• Technical acceptability includes meeting product descriptions, unique NDC, FDA approval, and cGMP compliance.

• Pricing must include a 0.5% Cost Recovery Fee.

• Offerors must submit proposals well before the deadline and confirm receipt.

• This acquisition is unrestricted.

• Other than small business concerns may be required to submit a subcontracting plan for contracts over $900,000.

• Offerors not manufacturing the items must submit a Letter of Commitment from the manufacturer.

• Offerors of covered drugs must have a Master Agreement (MA) and Pharmaceutical Pricing Agreement (PPA) in place with the VA.

• Attachments A and B list the VA and DoD Pharmaceutical Prime Vendors.

• Attachment C provides estimated annual requirements.

• Attachment D is a model outline for a Small Business Subcontracting Plan.

Solicitation / RFP / RFQ

This is a pre-solicitation notice for Request for Proposal (RFP) # 36E79726R0017, issued by the Department of Veterans Affairs (VA) National Acquisition Center. The procurement is for Famciclovir Tablets and is an unrestricted procurement. The intended recipients include the VA (including CMOPs and State Veterans Homes), Department of Defense (DoD) (including TriCare Mail Order Pharmacies), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

• Supply of Famciclovir Tablets in specific package sizes (30 tablets per bottle).

• Offerors must provide an uninterrupted source of supply.

• The successful offeror's unique NDC number and label will be the only one permitted on the product.

• VA labels must be able to adhere over the contractor's label.

• The contract will be awarded to a responsible offeror.

• The contract period will be for one year with four pre-priced one-year option periods.

• Distribution will be through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs.

• The solicitation will be issued electronically in commercial item format (FAR Part 12).

• Tentative closing date for proposals is April 7, 2026.

• All responsible sources may submit an offer.

• Interested offerors should continuously check SAM.gov for updates.

• This is an unrestricted procurement.

• Estimated annual requirements are provided for:

  • Famciclovir 125mg Tablets (30 count): 1,012 bottles
  • Famciclovir 250mg Tablets (30 count): 10,522 bottles
  • Famciclovir 500mg Tablets (30 count): 13,642 bottles

• The NAICS code is 325412.

• The point of contact is Richard Mahario (Richard.Mahario@va.gov, 708-786-5247).